Newron Pharmaceuticals SpA is a Italy-based clinical-stage biopharmaceutical company... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FRINX | 12.31 | -0.01 | -0.08% |
| Fidelity Advisor Real Estate Income A | |||
| FVILX | 6.20 | -0.02 | -0.32% |
| Forester Value I | |||
| HFAEX | 16.64 | -0.09 | -0.54% |
| Hartford Schroders Intl Cntrrn Val C | |||
| GMAPX | 30.84 | -0.34 | -1.09% |
| Goldman Sachs Small Cap Eq Insghts P | |||
| GSMAX | 21.07 | -0.32 | -1.50% |
| Goldman Sachs Small/Mid Cap Growth A | |||
A.I.dvisor tells us that NWPHF and MMIRF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NWPHF and MMIRF's prices will move in lockstep.
| Ticker / NAME | Correlation To NWPHF | 1D Price Change % | ||
|---|---|---|---|---|
| NWPHF | 100% | N/A | ||
| MMIRF - NWPHF | 30% Poorly correlated | N/A | ||
| ACET - NWPHF | 27% Poorly correlated | -8.14% | ||
| NTRB - NWPHF | 19% Poorly correlated | +3.17% | ||
| NURPF - NWPHF | 7% Poorly correlated | N/A | ||
| PRVCF - NWPHF | 4% Poorly correlated | +2.17% | ||
More | ||||